Skip to main content

Hims & Hers Health Inc - Class A (HIMS) Stock

Hims & Hers Health Inc - Class A Stock Details, Movements and Public Alerts

Stock Details

Hims & Hers Health Inc - Class A (HIMS), a prominent company in the consumer defensive sector within the household & personal products industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $55.52. Over the past 52 weeks, it has ranged between $15.73 and $72.98. This places the current price at 76.1% of its 52-week high and 253.0% above its 52-week low. Recent trading volume was recorded at 35,488,128. The 14-day Relative Strength Index (RSI) stands at 64.13, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $50.37 by 10.22%. Similarly, it is above its 200-day moving average of $42.08 by 31.94%. The MACD histogram is 1.36, indicating bullish momentum (MACD Line: 0.26, Signal Line: -1.11). The International Securities Identification Number (ISIN) for this stock is US4340772022. There are currently 2 active alerts set for HIMS by users.

Market Cap

$12.54B

52-Week High

$72.98

-23.92% from high

52-Week Low

$15.73

+252.96% from low

Avg Daily Volume

41,008,950

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

70.25

Above market average

Forward P/E

71.94

Earnings expected to decline

PEG Ratio

5.23

Potentially overvalued

Price to Book

22.29

EV/EBITDA

80.40

EPS (TTM)

$0.79

Price to Sales

6.23

Beta

2.14

More volatile than market

How is HIMS valued relative to its earnings and growth?
Hims & Hers Health Inc - Class A trades at a P/E ratio of 70.25, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 71.94 is higher than the current P/E, indicating analysts expect earnings to decline over the next year. The PEG ratio of 5.23 indicates a premium valuation even accounting for growth.
What is HIMS's risk profile compared to the market?
With a beta of 2.14, Hims & Hers Health Inc - Class A is significantly more volatile than the market. For every 10% market move, this stock tends to move 21% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 22.29 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

9.61%

Operating Margin

4.91%

Return on Equity

41.90%

Return on Assets

6.94%

Revenue Growth (YoY)

72.60%

Earnings Growth (YoY)

197.90%

How profitable and efficient is HIMS's business model?
Hims & Hers Health Inc - Class A achieves a profit margin of 9.61%, meaning it retains $9.61 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 4.91% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 41.90% and ROA at 6.94%, the company generates strong returns on invested capital.
What are HIMS's recent growth trends?
Hims & Hers Health Inc - Class A's revenue grew by 72.60% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings increased by 197.90% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against HOUSEHOLD & PERSONAL PRODUCTS industry averages for proper context.

Company Size & Market

Shares Outstanding

217.64M

Book Value/Share

$2.49

Asset Type

Common Stock

What is HIMS's market capitalization and position?
Hims & Hers Health Inc - Class A has a market capitalization of $12.54B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 217.64M shares outstanding, the company's ownership is relatively concentrated. As a participant in the HOUSEHOLD & PERSONAL PRODUCTS industry, it competes with other firms in this sector.
How does HIMS's price compare to its book value?
Hims & Hers Health Inc - Class A's book value per share is $2.49, while the current stock price is $55.52, resulting in a price-to-book (P/B) ratio of 22.28. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$49.45

10.93% downside potential

Analyst Recommendations

Strong Buy

0

Buy

3

Hold

7

Sell

1

Strong Sell

1

How reliable are analyst predictions for HIMS?
12 analysts cover HIMS with 25% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $49.45 implies -10.9% downside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on HIMS?
Current analyst recommendations:03 Buy, 7 Hold, 1 Sell, 1 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 14, 2025, 06:56 PM

Earnings Dates

Upcoming Earnings

Q3

Nov 10, 2025

Est. EPS: $0.11

In 57 days

Recent Earnings History

DateQuarterEstimated EPSActual EPSSurprise
Aug 11, 2025Q2$0.15--
May 5, 2025Q1$0.12$0.20+66.7%
Feb 24, 2025Q4$0.22$0.11-49.4%
Nov 4, 2024Q3$0.04$0.32+700.0%
Aug 5, 2024Q2$0.04$0.06+50.0%
May 6, 2024Q1$0.01$0.05+400.0%
Feb 26, 2024Q4$-0.02$0.01+150.0%
Nov 6, 2023Q3$-0.03$-0.04-33.3%

Technical Indicators

RSI (14-day)

64.13

Neutral

50-Day Moving Average

$50.37

10.22% above MA-50

200-Day Moving Average

$42.08

31.94% above MA-200

MACD Line

0.26

MACD Signal

-1.11

MACD Histogram

1.36

Bullish

What does HIMS's RSI value tell investors?
The RSI (Relative Strength Index) for HIMS is currently 64.13, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret HIMS's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.26 above the signal line at -1.11, with histogram at 1.36. This bullish crossover suggests upward momentum is building. The wide histogram confirms strong momentum. The 50-day MA ($50.37) is above the 200-day MA ($42.08), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 14, 2025, 06:56 PM

Active Alerts

Alert Condition
Price falls below
Threshold
$41.00
Created
Sep 4, 2025, 11:09 AM
Alert Condition
Price falls below
Threshold
$30.00
Created
Jun 2, 2025, 01:05 PM

Stay Ahead of the Market with Hims & Hers Health Inc - Class A Alerts

Set up price alerts for Hims & Hers Health Inc - Class A and get notified instantly when the price hits your target. Never miss an important price movement again.